Imaging endpoints for clinical trials in Alzheimer’s disease

As the need to develop a successful disease-modifying treatment for Alzheimer’s disease (AD) becomes more urgent, imaging is increasingly used in therapeutic trials. We provide an overview of how the different imaging modalities are used in AD studies and the current regulatory guidelines for their...

Descripción completa

Detalles Bibliográficos
Autores principales: Cash, David M, Rohrer, Jonathan D, Ryan, Natalie S, Ourselin, Sebastien, Fox, Nick C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304258/
https://www.ncbi.nlm.nih.gov/pubmed/25621018
http://dx.doi.org/10.1186/s13195-014-0087-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304258/
https://www.ncbi.nlm.nih.gov/pubmed/25621018
http://dx.doi.org/10.1186/s13195-014-0087-9

Ejemplares similares